Zap-and-Boost: new combo therapy targets tough cancers

NCT ID NCT07058948

First seen May 06, 2026 · Last updated May 08, 2026 · Updated 1 time

Summary

This study tests a special radiation method called lattice radiation therapy (LRT) combined with immunotherapy for people with advanced solid tumors that have stopped responding to standard treatments. About 30 participants will receive targeted high-dose radiation inside their largest tumor along with low-dose radiation to other spots, plus immunotherapy drugs. The goal is to see if this combination can shrink tumors and control the disease without causing severe side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Friendship Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, 100000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine

    RECRUITING

    Cangzhou, Hebei, 061000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Tianjin Medical University Cancer Institute & Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, 300000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.